A low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral control

AIDS

Volumn 29, Issue 15, 2015, Pages 2003-2007

  Assoumou, Lambert ^a,b   Weiss, Laurence ^c,d   Piketty, Christophe ^c   Burgard, Marianne ^e   Melard, Adeline ^d   Girard, Pierre Marie ^f   Rouzioux, Christine ^d,e   Costagliola, Dominique ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b INSTITUT PIERRE LOUIS D EPIDÉMIOLOGIE ET DE SANTÉ PUBLIQUE   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e Department of Pediatrics   (France)

^f HÔPITAL SAINT ANTOINE   (France)

Author keywords

cART interruption; HIV; HIV DNA

Indexed keywords

CD4 ANTIGEN; DNA; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA; RNA DIRECTED DNA POLYMERASE INHIBITOR; ANTIRETROVIRUS AGENT; VIRUS DNA;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CELL COUNT; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; GENETIC LOAD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTIVE VALUE; PRIORITY JOURNAL; REBOUND; TREATMENT INTERRUPTION; VIRUS LOAD; VIRUS REPLICATION; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; HIV INFECTIONS; MIDDLE AGED; MONONUCLEAR CELL; PROGNOSIS; TIME FACTOR; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; VIROLOGY;

ADULT; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; DNA, VIRAL; FEMALE; HIV INFECTIONS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PROGNOSIS; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD; WITHHOLDING TREATMENT;

EID: 84965028141     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000734     Document Type: Article

References (11)

1. Antiretroviral-Therapy-Cohort-Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 2008; 372:293-299.
2. Wong JK, Hezareh M, Gunthard HF, Havlir DV, Ignacio CC, Spina CA, et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 1997; 278:1291-1295.
3. Saag M, Deeks SG. How do HIV elite controllers do what they do? Clin Infect Dis 2010; 51:239-241.
4. Katlama C, Deeks SG, Autran B, Martinez-Picado J, van Lunzen J, Rouzioux C, et al. Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs. Lancet 2013; 381:2109-2117.
5. Saez-Cirion A, Bacchus C, Hocqueloux L, Avettand-Fenoel V, Girault I, Lecuroux C, et al. Posttreatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathog 2013; 9:e1003211.
6. Piketty C, Weiss L, Assoumou L, Burgard M, Melard A, Ragnaud JM, et al. A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadir. J Med Virol 2010; 82:1819-1828.
7. Lodi S, Meyer L, Kelleher AD, Rosinska M, Ghosn J, Sannes M, et al. Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion. Arch Intern Med 2012; 172:1252-1255.
8. Hocqueloux L, Prazuck T, Avettand-Fenoel V, Lafeuillade A, Cardon B, Viard JP, et al. Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection. AIDS 2010; 24:1598-1601.
9. Chun TW, Justement JS, Murray D, Hallahan CW, Maenza J, Collier AC, et al. Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication. AIDS 2010; 24:2803-2808.
10. Lafeuillade A, Poggi C, Hittinger G, Counillon E, Emilie D. Predictors of plasma human immunodeficiency virus type 1 RNA control after discontinuation of highly active antiretro-viral therapy initiated at acute infection combined with structured treatment interruptions and immune-based therapies. J Infect Dis 2003; 188:1426-1432.
11. Williams JP, Hurst J, Stohr W, Robinson N, Brown H, Fisher M, et al. HIV-1 DNA predicts disease progression and posttreat-ment virological control. Elife 2014; 3:e03821.